Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02955940
Title An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Healthcare Hematology-Oncology Santa Monica California 90404 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
New York Oncology Hematology Pc. Clifton Park New York 12065 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Renovatio Clinical Houston Texas 77005 United States Details
University of Texas, Md Anderson Cancer Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field